Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Raleigh, NC
NPI: 1013180108Primary Practice Location
REX HOSPITAL
4420 Lake Boone Trl, Raleigh, NC
Primary Employer
Rex Hematology Oncology Associates
rexhealth.com
HQ Phone
Get M.D. Joellen's Phone Numberphone_androidMobile
Get M.D. Joellen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 128 | 207 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 54 | 133 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 33 | 35 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 23 | 23 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 12 | 12 |
Authors: William Wood, Gretchen Kimmick, Ethan Basch, Raquel Reinbolt, Trevor Jolly, Elizabeth Dees
Journal: Cancer
Publication Date: 2020-04-21
Authors: Gretchen Kimmick, Raquel Reinbolt, Trevor Jolly
Journal: NPJ Breast Cancer
Publication Date: 2022-09-08
Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, p16INK4a.
Authors: Carey Anders, Raquel Reinbolt, Trevor Jolly, Elizabeth Dees
Publication Date: 2020-04-18
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Division of Cancer Control, NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP), Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Weight Loss Intervention, OTHER: Health Education Program
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, OTHER: Laboratory Biomarker Analysis, DRUG: Cyclophosphamide, DRUG: Paclitaxel, DRUG: Doxorubicin Hydrochloride
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: tamoxifen citrate, DRUG: everolimus, DRUG: anastrozole, DRUG: exemestane, DRUG: letrozole, DRUG: goserelin acetate, DRUG: leuprolide acetate
